Report: Global neuromodulation device market ripe for double-digit growth

The global neuromodulation devices market is up for some explosive, double-digit growth in the next few years, according to a new market study, set to soar from more than $2.7 billion in 2011 to 7 billion by 2018. Transparency Market Research sees a number of factors driving this, including the jump in chronic diseases for which neuromodulation technology could help (along with medications) more funding for this branch of research. Most of the growth so far has taken place in North America, according to the report, though the Asia-Pacific region will capture a lot of the new market expansion over the next few years.Companies including Medtronic ($MDT) and Boston Scientific ($BSX) should benefit from this trend; both have experienced healthy growth in their neuromodulation businesses. Item

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.